Arrowhead Pharmaceuticals, Inc. (ARWR): Price and Financial Metrics
Arrowhead Pharmaceuticals, Inc. (ARWR)
Today's Latest Price: $82.15 USD
1.41 (1.75%)
Updated Jan 19 4:00pm
Add ARWR to WatchlistSign Up
POWR Components:
Trade Grade Buy & Hold Grade Peer Grade Industry Rank
Industry Rank:
See all "A" rated Strong Buy stocks
ARWR Stock Summary
- With a price/sales ratio of 93.94, Arrowhead Pharmaceuticals Inc has a higher such ratio than 96.31% of stocks in our set.
- Over the past twelve months, ARWR has reported earnings growth of -253.2%, putting it ahead of only 7.83% of US stocks in our set.
- As for revenue growth, note that ARWR's revenue has grown -47.87% over the past 12 months; that beats the revenue growth of just 5.85% of US companies in our set.
- Stocks with similar financial metrics, market capitalization, and price volatility to Arrowhead Pharmaceuticals Inc are ARVN, CUE, ZYME, FGEN, and CCXI.
- ARWR's SEC filings can be seen here. And to visit Arrowhead Pharmaceuticals Inc's official web site, go to arrowheadpharma.com.
ARWR Stock Price Chart Interactive Chart >
ARWR Price/Volume Stats
| Current price | $82.15 | 52-week high | $86.75 |
| Prev. close | $80.74 | 52-week low | $19.51 |
| Day low | $80.61 | Volume | 538,500 |
| Day high | $83.45 | Avg. volume | 895,064 |
| 50-day MA | $72.94 | Dividend yield | N/A |
| 200-day MA | $49.48 | Market Cap | 8.44B |
Arrowhead Pharmaceuticals, Inc. (ARWR) Company Bio
Arrowhead Pharmaceuticals is a biopharmaceutical company developing targeted RNAi therapeutics. The company was founded in 1989 and is based in Pasadena, California.
Loading social stream, please wait...